FRIDAY, Sept. 5, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has created a "green list" import alert to stop unapproved and unverified glucagon-like peptide 1 (GLP-1) drug ingredients from entering the United States.
Dining under palm trees on a patio at Mar-a-Lago in December, President-elect Donald Trump reassured chief executives at pharmaceutical giants Eli Lilly and Pfizer that anti-vaccine activist Robert F. Kennedy Jr. wouldn’t be a radical choice to head the Department of Health and Human Services. “I think he’s going to be much less radical than […]
FRIDAY, Aug. 29, 2025 (HealthDay News) -- The U.S. Food and Drug Administration is now providing real-time, daily publication updates on adverse event data from its reporting system.
MONDAY, Aug. 25, 2025 (HealthDay News) -- The U.S. Food and Drug Administration is suspending the biologics license for the live-attenuated chikungunya vaccine, Ixchiq, in the United States. The move comes after reports of serious side effects in older adults similar to the symptoms of chikungunya virus.
Google searches for testosterone just hit their highest levels ever, turning a once clinical topic into one of the internet’s top health trends—and raising new questions about who's searching and why. Beyond middle-aged men, more women are now researching testosterone, and some of the fastest-rising queries reflect a mix of credible health concerns and viral speculation. To better understand these patterns, a new study from Invigor Medical identifies the U.S. states where testosterone-related search interest is highest, how this interest has evolved over the past decade, and which specific search terms are gaining the most traction, using the latest data from Google Trends.
GoodRx reports that in 2025, novel drug and biosimilar approvals lag slightly behind last year, while first generic approvals are ahead.